From discovery to translation across every domain
The Metabolon Verus™ Kit enables breakthrough research across therapeutic areas, research settings, and sample types.
From discovery to translation across every domain
The Metabolon Verus™ Kit enables breakthrough research across therapeutic areas, research settings, and sample types.
Built for diverse users
And broad research applications
The Metabolon Verus™ Kit is designed for any laboratory with an LC-MS platform. Whether you run a shared core facility or a focused research team, it delivers the same standardized, reproducible results.
Core Institutes
Run multiple projects per plate, each processed against matrix-specific libraries built on historical knowledge, maximizing instrument utilization and scientific rigor in a single workflow. Every user, regardless of study size, has direct access to the Integrated Bioinformatics Platform, a comprehensive analytical environment for statistical modeling, pathway analysis, and multi-omics integration.
CROs
Offer a metabolomics capability that is standardized, reproducible, and globally comparable, positioning the CRO as a premium partner for preclinical, late-stage studies, and sponsor-critical programs where reproducible data quality is non-negotiable. Detect pathway-level metabolic shifts linked to efficacy, safety, and patient response across in vitro, in vivo, and ex vivo models, providing clients with the biomarker and mechanistic evidence needed to make faster, better-informed go/no-go decisions.
New Labs
Deploy validated, standardized LC-MS workflows immediately, eliminating the typical 6–12 months of method optimization required to establish reliable metabolomics workflows in a new laboratory and dramatically reducing the total cost and time required to launch metabolomics capabilities.
Academic Researchers
Interrogate the exposome, microbiome, and host metabolic pathways within a single experiment, generating the biological breadth needed to understand how diet, environment, and metabolism converge on disease mechanisms.
Biotech
Integrate metabolomics with other data modalities to build a more complete biological picture, strengthening the evidence base for clinical success, label expansion, and patent protection.
Pharma
Incorporate metabolomics across clinical programs at any scale, from early translational studies through to multi-site Phase III trials, with data quality and reproducibility that meets the demands of each stage.
Built for diverse users and broad research applications
The Metabolon Verus™ Kit is designed for any laboratory with an LC-MS platform. Whether you run a shared core facility or a focused research team, it delivers the same standardized, reproducible results.
Core Institutes
Run multiple projects per plate, each processed against matrix-specific libraries built on historical knowledge, maximizing instrument utilization and scientific rigor in a single workflow. Every user, regardless of study size, has direct access to the Integrated Bioinformatics Platform, a comprehensive analytical environment for statistical modeling, pathway analysis, and multi-omics integration.
CROs
Offer a metabolomics capability that is standardized, reproducible, and globally comparable, positioning the CRO as a premium partner for preclinical, late-stage studies, and sponsor-critical programs where reproducible data quality is non-negotiable. Detect pathway-level metabolic shifts linked to efficacy, safety, and patient response across in vitro, in vivo, and ex vivo models, providing clients with the biomarker and mechanistic evidence needed to make faster, better-informed go/no-go decisions.
New Labs
Deploy validated, standardized LC-MS workflows immediately, eliminating the typical 6–12 months of method optimization required to establish reliable metabolomics workflows in a new laboratory and dramatically reducing the total cost and time required to launch metabolomics capabilities.
Academic Researchers
Interrogate the exposome, microbiome, and host metabolic pathways within a single experiment, generating the biological breadth needed to understand how diet, environment, and metabolism converge on disease mechanisms.
Biotech
Integrate metabolomics with other data modalities to build a more complete biological picture, strengthening the evidence base for clinical success, label expansion, and patent protection.
Pharma
Incorporate metabolomics across clinical programs at any scale, from early translational studies through to multi-site Phase III trials, with data quality and reproducibility that meets the demands of each stage.
